UPDATE: Quotient (QTNT) Tops Q4 EPS by 3c, Revenues Beat; Offers FY21 'Alba' Product Sales Guidance Above Revs. Views, Provides 1Q 'Alba' Product Sales Outlook

Go back to UPDATE: Quotient (QTNT) Tops Q4 EPS by 3c, Revenues Beat; Offers FY21 'Alba' Product Sales Guidance Above Revs. Views, Provides 1Q 'Alba' Product Sales Outlook

Quotient Limited Provides Update on COVID-19 Antibody Test Progress, Other Key Developments and Fourth Quarter and Full Year Fiscal 2020 Results

June 9, 2020 6:01 AM EDT

Developed a high performance COVID-19 Antibody Test
Several customer contracts signed for MosaiQ system and COVID-19 Antibody TestTransfusion Dx Expanded Immunohematology (IH) Field Trials have restarted following COVID related delaysInitial Serological Disease Screening (SDS) CE Mark obtainedContinued Strong Top Line Growth in Fourth Quarter and Full Year 

JERSEY, Channel Islands, June 09, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland,... More